TMC207-TiDP13-C208: Anti-bacterial Activity, Safety, and Tolerability of TMC207 in Participants With Multi-drug Resistant Mycobacterium Tuberculosis (MDR-TB).
Clinical trial NCT00449644 · COMPLETED
Trial details
- NCT number
- NCT00449644
- Sponsor
- Janssen Infectious Diseases BVBA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2010-03-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.